Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00888277 · ClinicalTrials.gov registry record

Bayer/Cognitive Assessments With Multiple Sclerosis Subjects

A clinical trial, sponsored by University of Louisville.

Completed
Registry status
74
Enrollment target

NCT00888277: Completed study, sponsored by University of Louisville.

NCT00888277 is a clinical trial that has completed, run by University of Louisville. The registered enrollment target is 74 participants. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00888277 has completed, sponsored by University of Louisville.

COMPLETED
Registry status
74 participants
Enrollment target

Study Summary

This study is designed to identify a brief screening evaluation for MS patients that is sensitive and specific to the MS population and which correlates with the findings of our standard-of-care neuropsychological assessments.

Trial Details

FieldValue
Enrollment Target 74 participants
Start Date 2009-05
Est. Completion 2010-01
University of Louisville

217 total trials

What the finished NCT00888277 record still lists

NCT00888277 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 74 participants, a relatively small participant target.

The record links to 0 conditions, and to 0 interventions.

NCT00888277 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT00888277 about?

NCT00888277 is a clinical study titled "Bayer/Cognitive Assessments With Multiple Sclerosis Subjects". This study is designed to identify a brief screening evaluation for MS patients that is sensitive and specific to the MS population and which correlates with the findings of our standard-of-care neuropsychological assessments.

What is the current status of trial NCT00888277?

This trial is currently completed. The enrollment target is 74 participants. The study started on 2009-05. Estimated completion is 2010-01.

Who is sponsoring clinical trial NCT00888277?

This trial is sponsored by University of Louisville, which has 217 total clinical trials registered on ClinicalTrials.gov.

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT03422731 · 74 participants · Early Phase 1

    Multi-modality Imaging and Collection of Biospecimen Samples in Understanding Bone Marrow Changes in Patients With Acute Myeloid Leukemia Undergoing TBI and Chemotherapy

  • NCT03804853 · 74 participants · NA

    Rehabilitation Following Reverse Total Shoulder Arthroplasty

  • NCT04065776 · 74 participants · NA

    Evaluation of Hippocampal-Avoidance Using Proton Therapy in Low-Grade Glioma

  • NCT04771156 · 74 participants · Phase 4

    Ketorolac in Palatoplasty

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT00888277, the US trial registry maintained by the National Library of Medicine. NCT00888277 (small enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.